Literature DB >> 26631949

Executive function deficits in pediatric cerebellar tumor survivors.

Elisabeth Koustenis1, Pablo Hernáiz Driever2, Leo de Sonneville3, Stefan M Rueckriegel4.   

Abstract

BACKGROUND AND AIMS: Besides motor function the cerebellum subserves frontal lobe functions. Thus, we investigated executive functions in pediatric posterior fossa tumor survivors.
METHODS: We tested information processing, aspects of attention, planning and intelligence in 42 pediatric posterior fossa tumor survivors (mean age 14.63 yrs, SD 5.03). Seventeen low-grade tumor patients (LGCT) were treated with surgery only and 25 high-grade tumors patients (HGCT) received postsurgical adjuvant treatment. We evaluated simple reaction time, executive functioning, i.e. visuospatial memory, inhibition, and mental flexibility using the Amsterdam Neuropsychological Tasks program, whereas forward thinking was assessed with the Tower of London-test. Intelligence was determined using the Wechsler Intelligence Scale. Ataxia was assessed with the International Cooperative Ataxia Rating Scale.
RESULTS: About one third of each patient group showed forward thinking scores below one standard deviation of the norm. Impaired forward thinking correlated significantly with degree of ataxia (r = -0.39, p = 0.03) but not with fluid intelligence. Both patient groups exhibited executive function deficits in accuracy and reaction speed in more difficult tasks involving information speed and attention flexibility. Still, HGCT patients were significantly slower and committed more errors. Working memory was inferior in HGCT patients.
CONCLUSION: Pediatric cerebellar tumor survivors with different disease and treatment related brain damage exhibit similar patterns of impairment in executive functioning, concerning forward thinking, inhibition and mental flexibility. The deficits are larger in high-grade tumor patients. The pattern of function loss seen in both groups is most probably due to comparable lesions to cerebro-cerebellar circuits that are known to modulate critical executive functions.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellum; Forward thinking; Posterior fossa tumors; Processing speed; Set shifting; Working memory

Mesh:

Year:  2015        PMID: 26631949     DOI: 10.1016/j.ejpn.2015.11.001

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

Review 1.  Cerebellar-Subcortical-Cortical Systems as Modulators of Cognitive Functions.

Authors:  Sarah V Clark; Eric S Semmel; Holly A Aleksonis; Stephanie N Steinberg; Tricia Z King
Journal:  Neuropsychol Rev       Date:  2021-01-29       Impact factor: 7.444

2.  DTI fiber tractography of cerebro-cerebellar pathways and clinical evaluation of ataxia in childhood posterior fossa tumor survivors.

Authors:  Myung Eun Oh; Pablo Hernáiz Driever; Rajiv K Khajuria; Stefan Mark Rueckriegel; Elisabeth Koustenis; Harald Bruhn; Ulrich-Wilhelm Thomale
Journal:  J Neurooncol       Date:  2016-10-26       Impact factor: 4.130

3.  Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents.

Authors:  Allison P Fisher; Jamie Patronick; Cynthia A Gerhardt; Krestin Radonovich; Ralph Salloum; Shari L Wade
Journal:  Pediatr Blood Cancer       Date:  2021-05-24       Impact factor: 3.838

4.  Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors.

Authors:  Claudia Cavatorta; Silvia Meroni; Eros Montin; Maria C Oprandi; Emilia Pecori; Mara Lecchi; Barbara Diletto; Ombretta Alessandro; Denis Peruzzo; Veronica Biassoni; Elisabetta Schiavello; Marco Bologna; Maura Massimino; Geraldina Poggi; Luca Mainardi; Filippo Arrigoni; Filippo Spreafico; Paolo Verderio; Emanuele Pignoli; Lorenza Gandola
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

5.  White matter hyperintensity volumes are related to processing speed in long-term survivors of childhood cerebellar tumors.

Authors:  Holly A Aleksonis; Lisa C Krishnamurthy; Tricia Z King
Journal:  J Neurooncol       Date:  2021-07-06       Impact factor: 4.130

6.  Story time turbocharger? Child engagement during shared reading and cerebellar activation and connectivity in preschool-age children listening to stories.

Authors:  John S Hutton; Kieran Phelan; Tzipi Horowitz-Kraus; Jonathan Dudley; Mekibib Altaye; Thomas DeWitt; Scott K Holland
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

7.  Neuropsychological Consequences for Survivors of Childhood Brain Tumor in Malaysia.

Authors:  Hamidah Alias; Sie Chong D Lau; Ilse Schuitema; Leo M J de Sonneville
Journal:  Front Psychol       Date:  2018-05-29

8.  Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.

Authors:  Thomas Traunwieser; Daniela Kandels; Franz Pauls; Torsten Pietsch; Monika Warmuth-Metz; Brigitte Bison; Juergen Krauss; Rolf-Dieter Kortmann; Beate Timmermann; Ulrich-Wilhelm Thomale; Peggy Luettich; Anne Neumann-Holbeck; Tanja Tischler; Pablo Hernáiz Driever; Olaf Witt; Astrid K Gnekow
Journal:  Neurooncol Adv       Date:  2020-08-08

Review 9.  Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors.

Authors:  Peter L Stavinoha; Martha A Askins; Stephanie K Powell; Natasha Pillay Smiley; Rhonda S Robert
Journal:  Bioengineering (Basel)       Date:  2018-09-11

10.  Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.

Authors:  Holger Ottensmeier; Paul G Schlegel; Matthias Eyrich; Johannes E Wolff; Björn-Ole Juhnke; Katja von Hoff; Stefanie Frahsek; Rene Schmidt; Andreas Faldum; Gudrun Fleischhack; Andre von Bueren; Carsten Friedrich; Anika Resch; Monika Warmuth-Metz; Jürgen Krauss; Rolf D Kortmann; Udo Bode; Joachim Kühl; Stefan Rutkowski
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.